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patients who are frequent ED users. Objectives: We hy-
pothesized that the care of frequent ED users would
improve using a citywide care coordination program com-
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measured by fewer ED visits by and decreased controlled
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498providers were contacted by phone. Each patient was dis-
cussed at a community multidisciplinary meeting where
recommendations for ED care were formed. The ED care
recommendations were stored in an ED information ex-
change system that faxed them to the treating ED provider
when the patient presented to the ED. The control arm was
subjected to treatment as usual. Results: The intervention
armexperienceda 34%decrease (incident rate ratios= 0.66,
p < 0.001; 95% confidence interval 0.57–0.78) in ED visits
and an 80% decrease (odds ratio = 0.21, p = 0.001) in the
odds of receiving an opioid prescription from the ED rela-
tive to the control group. Declines of 43.7%, 53.1%,
52.9%, and 53.1% were observed in the treatment group
for morphine milligram equivalents, controlled substance
pills, prescriptions, and prescribers, respectively. Conclu-
sion: This RCT showed the effectiveness of a citywide ED
care coordination program in reducing ED visits and
controlled substance prescribing.  2016 The Author(s).
Published by Elsevier Inc. This is an open access article un-
der the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
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Program to Reduce Prescription Opioid-Related ED Visits 499An increase in overdose deaths related to opioid analge-
sics over the past 15 years has amplified the importance
of safely managing prescription opioid medications pre-
scribed by all physicians, including those who practice
in emergency departments (EDs). Pain is the most com-
mon reason people seek care in EDs (1). Among all adult
ED patients with pain-related complaints, approximately
43% are administered an opioid analgesic, and 26%
receive a discharge prescription for an opioid during a
pain-related ED visit (2). Roughly one in five prescrip-
tions written by emergency medicine practitioners is for
an opioid analgesic (3). ED providers find it difficult to
balance effective pain treatment against risk for addiction
and overdose (4).
Designed and outfitted for the rapid treatment of acute
conditions, the ED lacks the resources for management of
chronic pain (5). Such management is difficult in a setting
of brief patient–physician interactions, with little or no
access to primary care medical records, with small
amounts of useful data buried within a voluminous elec-
tronic health record that is too lengthy and ill-formatted
to efficiently and fully search, and with little training in
the treatment of chronic pain or addiction. As a result,
the care coordination process tends to break down when
patients seek treatment for chronic pain in the ED. More-
over, the lack of timely, accurate information leads to dif-
ficulty in appropriately limiting controlled-substance
prescribing in the ED. This incomplete substance abuse
history makes it very challenging to discuss chemical de-
pendency treatment with appropriate patients. These gaps
make it possible for patients with drug addiction to use
the ED to obtain controlled prescription drugs (6).
Of particular concern in this context is a small subset
of patients who use the ED frequently. It has been re-
ported that 3% to 4% of patients account for up to 20%
of total ED visits (7). Frequent ED users are a particularly
difficult population to treat appropriately due to a lack of
consistently implemented ED treatment plans, which are
routinely employed in the primary care setting. Patients
who frequent the ED are more likely to have complex
problems, be socially and economically disadvantaged,
covered byMedicaid orMedicare, have comorbid psychi-
atric and substance abuse conditions, be in overall poor
health, and have made frequent outpatient clinic visits
(8,9). Some ED visitors go to multiple EDs in their
communities to obtain prescriptions for drugs prone to
abuse, a behavior known as ‘‘drug seeking’’ (10). Many
efforts, such as statewide prescription monitoring pro-
grams, patient alert lists, and a non-narcotic protocol in
the ED, have been implemented with unclear effect on
ED opioid prescribing practices (11–13).
ED-specific care coordination programs are a novel
strategy that seems to be effective at assisting frequent
users with obtaining the appropriate level of care in theappropriate setting (14). Care coordination programs
represent a client-centered, assessment-based, interdisci-
plinary approach to integrating health care and social sup-
port services wherein the individual’s needs and
preferences are assessed, a care plan for ED treatment
is developed, and services are managed and monitored
by an identified case manager following evidence-based
standards of care. ED care coordination programs that
do not operate in all area EDs are not effective at deterring
patients from frequenting nonparticipating EDs, and their
outcomes are skewed (14).
In 2006, Providence Sacred Heart Medical Center and
Children’s Hospital in Spokane, WA, established a city-
wide care coordination program, Consistent Care (CC),
to offer ED providers at all metropolitan hospitals real-
time ED treatment plans for patients at risk for using the
ED to obtain prescription analgesics for inappropriate
use. A pre-post analysis of a convenience sample of CC
patients revealed a significant reduction in ED visits and
indicated that the program was cost saving from the hos-
pital’s perspective (15). Although these results were
encouraging, a more rigorous evaluation of this program
in a new community was needed, one that also evaluated
the program’s impact on controlled-substance prescribing.
We conducted a multisite, randomized controlled trial
(RCT) of the effectiveness of an information-exchange-
assisted citywide ED care coordination program for the
management of frequent ED users exhibiting opioid-
prescription-seeking behavior in the Tri-Cities area of
south-central Washington, 135 miles southwest of Spo-
kane. We sought to determine if the intervention
decreased participants’ frequency of ED visits, the
controlled-substance-prescribing practices of ED clini-
cians located at the study sites, and the number of
controlled substance prescriptions frequent users
received from all providers in the state relative to a
treatment-as-usual (TAU) control. If the intervention is
shown to be effective, it might provide a management
approach that can be implemented in cities nationwide.
Such care coordination might ultimately reduce
morbidity andmortality risks associated with prescription
opioids and reduce related health care expenditures.METHODS
Study Design and Setting
We utilized a multisite, RCT design. The study took place
at three hospital-based EDs located in a region composed
of three contiguous cities with a total population of
242,000. The number of combined yearly ED visits for
these hospitals was approximately 112,000. The trial
included all EDs in the metropolitan area. Each ED was
operated independently in separate health care systems.
500 D. Neven et al.Two of the hospitals operated internal programs for moni-
toring frequent ED users prior to the RCT; however, there
were no communication or coordination efforts with the
other hospitals. Patients enrolled in these internal pro-
grams were excluded. This study received Institutional
Review Board (IRB) approval from Washington State
University and each of the hospitals.
The hospital information systems of the three study
hospitals were connected to the Emergency Department
Information Exchange (EDIE), an Internet-based ED
care coordination application. Each hospital imple-
mented a Health Level 7 admission, discharge, and trans-
fer data feed from the hospital information system to the
EDIE system. With the EDIE system, hospitals can track
and analyze patient ED utilization patterns, compile his-
torical patient data (e.g., diagnoses, medications, al-
lergies, discharge summaries), manage patient care by
creating ED Care Guidelines that are faxed to the ED pro-
vider in real-time, and document care coordination inter-
ventions provided to the patient.
Participants
Potential participants were identified by aggregating the
ED census from all three hospitals and ranking patients
according to their frequency of ED visits in the 12 months
prior to January 2012. Patients who met the following
criteria were included in the study: 1) five or more ED
visits to study hospitals in the previous 12 months, 2) at
least half of the ED visits attributed to pain complaints
or drug-seeking behaviors, and 3) age 18 years or older.
Patients were excluded who had 1) a medical condition
that in the principal investigator’s (PI) or the study med-
ical director’s judgment might interfere with safe study
participation such as a terminal diagnosis; 2) a docu-
mented cancer diagnosis suspected of causing chronic
pain; 3) acute suicidal behaviors (overt attempts or cur-
rent serious suicidal intention) documented in the medi-
cal record; or 4) high frequency ED utilization for
medical reasons other than pain, such as serial
inebriation. Patients were randomly assigned to either
the intervention group or TAU group using the
urn randomization procedure (16). To minimize partici-
pant selection effects, a waiver of consent was obtained
from the IRB, and participants were not informed of study
participation. The waiver of consent prevented patients
from being influenced to participate or not based on their
impression that participation would affect being pre-
scribed opioids during their ED visit.
Patient-specific care guidelines were automatically
faxed to the ED by the EDIE system and placed on the pa-
tient’s chart within 3 minutes of the patient presenting to
the ED. Enrollment in the intervention group was evident
to ED providers by virtue of the faxed ED CareGuidelines beingmade part of the patient’s ED chart. Pro-
viders were not informed when patients in the TAU group
presented to the ED. The ED Care Guidelines were rec-
ommendations and not mandatory. ED providers were
educated to use clinical judgment when providing care
to the patient. Patient charts of participants were moni-
tored regularly by the study research coordinator for
adverse events. Participants in the intervention and TAU
group were removed from the study if they presented to
the ED with suicidal behaviors.
Enrollment
The study enrollment period was March 2012 to July
2012. Participants in the intervention group received city-
wide care coordination for 1 year after entering the study.
Participants in the control group were observed for 1 year
after entering the study. The trial ended in July 2013.
For patients in the intervention group, the enrollment
protocol started with one of the three hospital-based ED
case managers reviewing the medical, mental, and social
history contained in ED visit medical records from all
the hospitals in the study area. Next, the ED case man-
ager called all the current care providers of patients in
the intervention group, including any substance abuse
and mental health providers, to explain the program
and solicit information on the patient and their ED treat-
ment recommendations. Patients in the intervention
group were sent a letter and contacted by phone to
inform them of enrollment in the program. The ED
case manager solicited their input regarding their
frequent ED use, and offered to assist the patient in ob-
taining needed care. Thereafter, an ED case manager at-
tempted to meet the patient whenever they presented to
the ED. Patients that visited the ED when case manage-
ment was not present received a follow-up call the next
day to discuss their ED visit. Patients were enrolled us-
ing this process every 2 weeks during the study enroll-
ment period in groups of 10–12 patients, and then
discussed at biweekly multidisciplinary committee
meetings.
The role of the multidisciplinary committee was to
make recommendations for individualized ED Care
Guidelines and for care coordination interventions on
the patients in the intervention group. It included social
service staff, a pharmacist, a chaplain, ED providers
and staff from all three hospital sites, mental health and
substance abuse providers, and study staff, including
the Study PI and Research Coordinator. Cases were pre-
sented by an ED case manager from one of the three hos-
pitals and included any relevant medical history and an
identified reason behind the frequent ED visits. Meetings
were held at each of the three study sites. The committee
held eight meetings over the 14-week enrollment period.
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the EDIE system for follow-up by involved agencies
and case management staff.
The ED Care Guidelines were written by the research
coordinator, who is also a certified nurse case manager,
based on the recommendations of the committee. The
Guidelines included eight sections:
1. Security Summary: An assessment of the security
risk of the patient to ED staff and a description of
any patterns of dangerous behavior demonstrated
on previous ED visits.
2. Opioid Recommendation: A recommendation from
the multidisciplinary committee not to administer
or prescribe opioids from the ED when objective
findings to substantiate complaints of pain are ab-
sent.
3. Primary Care Provider: The patient’s primary care
provider and clinic name, including the phone
number.
4. Chronic Pain Medication: Information about
whether the patient has entered into an opioid
agreement with their provider or is receiving a
scheduled supply of controlled substances.
5. CT Scan Statement: A statement summarizing the
number of CT scans the patient has received in
the last 3 years and how often CT scans had signif-
icant findings.
6. ED Visit Summary: A table of all ED visits made
by the patient in the metropolitan area for the
past 2 years.
7. Referrals: A statement regarding the referrals rec-
ommended by the multidisciplinary committee,
such as chemical dependency evaluation, psychiat-
ric evaluation, or physical therapy evaluation.
8. Past Medical History: A compilation of diagnoses
listed on medical records, as well as a summary
of other pertinent psychosocial history factors ob-
tained from hospital medical records.
The guidelines were entered into the EDIE system and
were also provided to the assigned Primary Care Pro-
vider and other members of the care team at the conclu-
sion of the enrollment process for each participant in the
intervention arm. The ED Care Guidelines served as a
permanent care coordination document that could be up-
dated as the patient’s situation changed. Patients were
contacted by the ED case manager as needed during
the 12-month observation period to arrange for services
that were thought necessary, such as specialty referrals
or primary care follow-up. This allowed the ED Case
Manager and hospital staff to work toward addressing
identified gaps in care at every ED visit. For all patients,
the multidisciplinary committee recommended the ED
provider not provide any controlled substances ifobjective findings to support the pain complaints were
not observed. Examples of objective findings would
include ED imaging studies showing acute pathology
or physical examination findings that are consistent
with acute pathology. The study team educated the ED
providers and hospital staff about the importance of
following the ED Care Guidelines shortly after begin-
ning the study and periodically throughout the course
of the study. When ED care guidelines were not fol-
lowed, follow-up education was provided to promote
behavior change by the ED providers.
Care Coordination
Each hospital employed an ED case manager that per-
formed care coordination for all ED patients. The study
reimbursed each hospital for 10 hours per week of the
ED case manager’s time to provide ED care coordination
for study participants. Patients in the intervention group
were assigned to an ED case manager at the ED they
most frequented. The role of the ED case managers was
to identify the factors contributing to ED use and to
develop interventions to address the issues. This included
addressing any untreated mental health or substance
abuse issues, finding resources for basic needs (housing,
transportation), connecting study participants to primary
care, and providing education on alternatives to the use of
the ED for nonemergent issues. The case managers also
served as a liaison to identify a sole prescriber in the com-
munity for any individuals visiting multiple prescribers
for controlled substances.
To determine whether study participants were
acquiring controlled substance prescriptions outside of
the study area, we retrieved data on Schedule II and III
prescriptions from the Washington State Prescription
Drug Monitoring Program (PDMP). The PDMP collects
information on all controlled-substance prescriptions
dispensed by all pharmacies in Washington State. The
PDMP started mandatory collection of such information
in October 2011, which was 5 months prior to the enroll-
ment of the first group of study participants. Due to the
limited prescription history in the PDMP, we analyzed
PDMP outcomes only for the final month of the interven-
tion, when we could compare all patients in the interven-
tion and TAU groups during the same calendar month.
This was the 10th month of the intervention. We
compared aggregate data for the two groups because state
privacy regulations prevented PDMP data from being re-
ported on individual patients. In addition to examining
whether the intervention decreased the overall number
of controlled substance prescriptions, we also determined
whether patients returned to the ED sooner if they
were provided a controlled-substance prescription from
the ED.
502 D. Neven et al.Statistical Analysis
Chi-squared and t-tests were used for categorical and
continuous variables, respectively, to assess the success
of the randomization procedure (see Table 1). The 12-
month observation period for each participant began
when the participant was enrolled in the study. We used
generalized estimating equations (GEE) to compare the
groups with respect to longitudinal ED visits (i.e., as a
count; using the Poisson family and a log link function)
per month during the 12-month observation period, and
whether or not patients had one or more ED visits
(1 = yes, 0 = no; using the binomial family and a logit
link function) during any given month for each of the
12 months of the observation period. We report incident
rate ratios (IRRs) for monthly counts of ED visits and
odds ratios (ORs) for monthly ED visits (yes/no). We
used independent sample t-tests to compare total number
of ED visits, mean number of prescriptions on discharge
(both opioid and nonopioid controlled substances), and
longest consecutive period between ED visits. We also
employed nonparametric alternatives to the independent
samples t-test (i.e., adjusting for unequal variances) given
potential assumption violations. We also utilized GEE for
the secondary outcome of whether patients received an
opioid in the ED or not. Using outcomes data from the
PDMP, we calculated the prevented fraction (or propor-
tion of incidents prevented by treatment in %) due to
the intervention exposure compared to the control expo-
sure using person-months for each group in the last
observable uniform 1-month period (i.e., as noted above,
month 10 of the intervention) (17,18). We utilized an
alpha level of 0.05 (two-tailed) as the threshold for
statistical significance in all tests. Stata 13.0 (College
Station, TX) was used for all statistical analyses.
RESULTS
We evaluated 255 patients for inclusion in the study and
excluded 90 that did not meet study criteria. The remain-Table 1. Participant Characteristics at Baseline Across
Study Groups, Citywide ED Care Coordination
Trial, March 2012 to July 2013
Characteristic
Intervention
Group
(n = 79)
Control
Group
(n = 76)
p-
Values
Age in years, Mean (SD) 37.82 (13.37) 37.12 (12.90) 0.74
Percent female, % (n) 68.42 (57) 72.15 (52) 0.61
ED visits in 2011, Mean (SD) 16.67 (6.76) 15.46 (5.60) 0.23
Number of opioid
prescriptions from the ED
in prior 12 months,
Mean (SD)
3.97 (3.97) 3.65 (3.69) 0.61
ED = emergency department; SD = standard deviation.ing 165 were randomized (Figure 1). Five participants
were removed from the intervention group during the
course of the trial: 2 due to suicidal behavior, 2 due to
death, and 1 due to a new cancer diagnosis. Five partici-
pants were removed from the control group: 4 due to sui-
cidal behavior and 1 due to death. One of the deaths was
due to a tricyclic overdose and one death was due to
hanging. The cause of the third death is unknown.
The groups did not differ on gender, mean age, number
of ED visits in the previous 12 months, or number of
opioid prescriptions from the ED in the previous
12 months (Table 1). All 155 patients in the study had at
least 11 ED visits during the 12-month period prior to
January 2012, at least 50% of which were attributed to a
pain complaint. We also compared the distribution of
the primary reasons for participants being lost to follow-
up due to study disenrollment (i.e., death, suicidality, ter-
minal diagnosis). The groups did not differ with respect to
the reason for loss of follow-up (data not shown).
Participants in the intervention arm of the trial experi-
enced an approximate 34% decrease in the incidence of
ED visits (IRR 0.663, p < 0.001; 95% confidence interval
[CI] 0.569–0.775) relative to the control group across the
12-month treatment period (Table 2). The odds of making
any visit to the EDwere about 33% less in the intervention
group compared to the control group (OR 0.673,
p < 0.001; 95% CI 0.538–0.841) during treatment as
well (Table 2). The overall likelihood of visiting the ED
for all study participants went down during the 12-
month study observation period by approximately 4%
per month (OR 0.961, p = 0.001; 95% CI 0.932–0.991)
(Figure 2). Lastly, the GEE analysis on whether or not par-
ticipants received an opioid prescription from the ED pro-
vider (yes/no) during each 1-month period found an 80%
decrease in the odds of those in the treatment group
receiving an opioid prescription from the ED provider
compared to those in the control group (OR 0.21,
p = 0.001; 95% CI 0.122–0.353) over time (Table 2).
Participants in the intervention group visited the ED
fewer times on average than those in the control group
(Table 3). Participants in the intervention group received
a significantly smaller mean number of prescriptions
written on ED discharge per person compared to those
in the control group. Nonparametric tests produced the
same result for all of the above tests for our secondary
outcomes (data not shown).
The number of opioid prescriptions written per partic-
ipant was predictive of ED visit-free days (B = 16.42,
p < 0.001) while controlling for treatment group assign-
ment. For every opioid prescription written, there was
an approximate 16-day decrease in an individual’s
longest consecutive ED visit-free days. There was no dif-
ference between the intervention group (M = 149.93,
SD = 80.26) and the control group (M = 146.83,
Analyzed: (n = 155)
Excluded from Analysis: (n=10)
Lost to follow-up (n = 3 death): 2 in 
intervention, 1 in control arm
Removed from RCT (n = 6 suicidal, 1 = 
terminal diagnosis):  3 in intervention, 4 
in control arm
Total Allocation
(n = 165)
Follow-Up
Excluded: (n = 90)
Did not meet inclusion criteria 
Allocated to Control Arm:
(n = 83)
Treated as usual:
(n = 83)
Allocated to Intervention Arm:
(n = 82)
Received allocated intervention:
(n = 82)
Randomized
Enrollment
Assessed for Eligibility:
(n = 255)
Figure 1. Consort diagram for eligibility assessment and randomization to one of two treatment arms for the clinical trial. City-
wide ED [Emergency Department] Care Coordination Care Trial, March 2012 to July 2013. RCT = randomized controlled trial.
Program to Reduce Prescription Opioid-Related ED Visits 503SD = 80.08; t = 0.23, p = 0.815) on an individual’s
longest number of consecutive ED visit-free days during
the intervention (data not shown).Table 2. ED Visit and ED Opioid Prescribing Ratios for Intervention
Trial March 2012 to July 2013
Outcomes
Treatment Effect (0 = Con
Ratio 95
ED visit incidence (count per month) 0.663* 0.56
ED visit (yes/no per month) 0.673† 0.53
Opioid incidence in ED (count per month) 0.208* 0.12
Opioid in ED (yes/no) 0.198† 0.12
ED = emergency department; CI = confidence interval.
* Odds ratio.
† Incident rate ratio.The two groups differed markedly by the last uniform
observational month for this trial (month 10) (Table 4).
The total number of pills dispensed, morphine milligramand Control Groups, Citywide ED Care Coordination Care
trol Arm, 1 = Intervention Arm) Time Effect (Per Month)
% CI p Value Ratio 95% CI p Value
9–0.775 <0.001 0.962* 0.942–0.982 0.001
8–0.841 <0.001 0.961† 0.932–0.991 0.001
2–0.353 <0.001 0.983* 0.926–1.044 0.586
0–0.325 <0.001 1.019† 0.967–1.074 0.490
Figure 2. Emergency department (ED) visits across 12-
month treatment period between control and treatment
arms. Citywide ED Care Coordination Care Trial, March
2012 to July 2013.
504 D. Neven et al.equivalents, and opioid prescriptions filled in the treat-
ment group statewide was nearly half that of the control
group. The number of prescriptions for nonopioid
schedule II and III prescriptions was two-thirds fewer
for the treatment group (total = 28) compared to the con-
trol group (total = 84). The number of opioid prescrip-
tions with a refill was four in the treatment group and
10 in the control group, which is the only nonstatistically
significant finding from the PDMP outcomes. Lastly,
therewere a total of 23 unique prescribers in the treatment
group and 40 in the control group.
DISCUSSION
This RCT has demonstrated that a citywide ED care co-
ordination program combined with an ED care coordina-
tion information system can reduce ED visits and
controlled substance prescribing by ED providers. Data
from the state’s prescription drug-monitoring program
indicated that participants in the intervention group
received fewer controlled-substance prescriptions and
pills from all prescribers than participants in the TAU
group.Table 3. ED Visits and Controlled Substance Prescriptions From th
Trial, March 2012 to July 2013
Interven
ED visits 5
Opioid prescriptions from the ED 0
Nonopioid controlled substance prescriptions from the ED 0
ED = emergency department.A variety of other efforts to improve care and reduce
visits of frequent ED users have been attempted. For
example, ‘‘Patient Alert’’ lists have been used to reduce
ED drug-seeking behaviors with limited success (12).
The citywide ED care coordination program studied in
this RCT was inspired by a program started in Calgary,
Canada for frequent ED users with headache complaints
that involved all four Calgary hospitals; however, the pro-
gram lacked computerized information sharing and did
not proceed to full implementation (19). A small study
found that when ED patients were told they would be de-
nied further narcotic treatment in their facility, patients
received a prescription drug 93% of the time in another
hospital and 71% of the time in the same hospital at a sub-
sequent visit (20). The use of a strict non-narcotic proto-
col in the ED for chronic pain patients was found to
reduce overall ED and other clinic visits in a select pop-
ulation (21). Research on intensive case management of
individuals frequently using the ED has found mixed re-
sults. Findings from two reports suggest that case man-
agement may be effective, yet other studies have found
no decline in, or increased utilization of, the ED (22–
25). Sample sizes for each of these studies were
relatively small (ranging from 24–70). A major
limitation of these studies was the use of coordination
in a single hospital or hospital system, and ED visits
were not measured at all nearby EDs.
This study examined the combination of an ED care co-
ordination program with timely data on patient prescrip-
tion histories in all hospitals in one metropolitan area. A
small study has suggested that immediate access to infor-
mation from a PDMP could significantly affect the emer-
gency physician’s controlled substance prescribing (26).
The availability of similar information to the ED provider
in real timemight bemore effectivewhen coupledwith co-
ordinated community care for the patients. Notably, in
2013 Washington State mandated the use of the
information-sharing platform used in this study without
mandating care coordination services, and found only a
10% reduction in ED visits per year after implementation
(13,27).
Some of the declines in outcomes noted in both study
groups might have been due to regression to the mean or
to other interventions being introduced in Washingtone ED Over 12 Months; Citywide ED Care Coordination Care
tion Mean (SD) Control Mean (SD) t Value p Value
.59 (4.65) 8.49 (7.02) 3.03 0.003
.28 (0.74) 1.44 (2.05) 4.80 <0.001
.39 (0.79) 1.69 (2.31) 4.80 <0.001
Table 4. Prescription Use From All Sources as Reported by the PDMP* by Intervention Group, During Month 10 of the
Intervention; Citywide ED Care Coordination Care Trial, March 2012 to July 2013
Prescription Use in Schedules II and III Intervention (n = 76) Control (n = 79)
Prevented Fraction† of Use Due to
Intervention (%) (95% CI) p-Value
Pills dispensed 2682 5946 53.1 (51.0–55.2) <0.001
Morphine milligram equivalents 3499 6459 43.7 (41.4–45.9) <0.001
Total opioid prescriptions 60 128 52.9 (36.2–65.2) <0.001
Nonopioid controlled substances 28 84 65.4 (47.9–77.0) <0.001
Opioid prescriptions with a refill 4 10 58.4 (27.8–86.5) 0.136
Unique prescribers 23 40 53.1 (52.6–57.8) 0.047
CI = confidence interval; ED = emergency department.
* Washington State Prescription Drug Monitoring Program.
† Calculated as the percent difference between the intervention and control group rates during month 10.
Program to Reduce Prescription Opioid-Related ED Visits 505State during this time period (27). For example, in 2010,
Washington State enacted a law (ESHB 2876) requiring
rules on pain management to be adopted by practitioners.
This bill outlined dosing criteria, consultation guidance,
treatment review, continuing education requirements,
and also cited exceptions to these requirements. Although
most ED providers fell into the exception of managing
acute pain caused by injury or surgery, their awareness
of these rules may have affected their prescribing prac-
tices (28). The decline noted in the control group might
also have been due, in part, to a spillover effect: sensi-
tizing the local providers about the problem of opioid
abuse during our communications regarding patients in
the intervention group. Anecdotally, providers reported
being more empowered to say ‘‘No’’ in prescribing these
medications to any patients. However, one would expect
the same influence to be exerted in the TAU group.
Limitations
This study has several limitations. Providing information
as to whether or not individuals sought treatment via pri-
mary care and what type of care they received was not
within the scope of this study. Patients might have gone
to primary care providers instead of returning to EDs in
the study area. Only ED visits made to the three metropol-
itan hospitals were measured, and it is unknown to what
extent patients made ED visits outside the metropolitan
area. However, the risk is estimated to be small, as the
closest hospital is over 30 miles away. The PDMP data
show a decrease in all dispensed controlled-substancemet-
ricsmeasured across the state. Another potential concern is
that patients turned to other means to obtain opioids (e.g.,
theft, greater use of family or friends’ medications), but we
did not attempt to measure such behavior. It is also un-
known whether patients might have filled prescriptions
out of state to avoid being recorded in the Washington
State PDMP. The closest Oregon town is 30 miles from
the study area. Schedule IV controlled substances include
many substances of abuse sought by frequent ED users,including alprazolam, lorazepam, and clonazepam. This
study did not retrieve information on schedule IV
controlled substances from the PDMP.
Finally, it is unknownwhether the intervention had pos-
itive or negative effects on the management of chronic
health problems in these patients or on their subsequent
risk of health problems related to substance abuse, such
as overdose. One study that reported a case management
system for frequent ED users found both a reduction in
EDuseandan improvement inpsychosocial problems (29).CONCLUSIONS
To our knowledge, this is the first RCT to show the effec-
tiveness of coordinating ED care across all hospitals in a
metropolitan area using an ED care coordination informa-
tion system to reduce ED visits and opioid prescribing
among frequent ED users. Expanding the use of ED care
coordination information systems would allow other hos-
pitals to appropriately treat patients that they suspect are
moving from hospital to hospital in an effort to obtain
controlled substances. The goal should be not only to iden-
tify and treat these individuals appropriately in the ED, but
also to provide follow-up care coordination so they can
obtain the treatment needed for the long-termmanagement
of their condition(s). Sharing ED care plans between all
EDs could result in patients receiving a consistentmessage
from all emergency providers, which could lead to long-
term behavior modification that results in healthier life-
styles. The effectiveness of this intervention could be
extended to other frequent ED user groups with chronic
conditions where the patient is resistant to long-term
behavior modification, such as congestive heart failure,
chronic obstructive pulmonary disease, and diabetes.
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Program to Reduce Prescription Opioid-Related ED Visits 507ARTICLE SUMMARY
1. Why is this topic important?
Opioid abuse is a major cause of death and mortality in
the United States. Frequent emergency department (ED)
users tax the health care system.
2. What does this study attempt to show?
This study shows that an ED care coordination program
operating in cooperation with all EDs within a community
are effective.
3. What are the key findings?
ED visits by frequent ED users were reduced, and
controlled substance prescribing was reduced by a com-
munity ED care coordination program.
4. How is patient care impacted?
Patients with frequent ED use for pain complaints
should be referred to a community-wide ED care coordi-
nation program.
